NCT03678883 2024-11-079-ING-41 in Patients with Advanced CancersActuate Therapeutics Inc.Phase 2 Active not recruiting350 enrolled
NCT03878524 2024-03-04Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME TrialOHSU Knight Cancer InstitutePhase 1 Terminated2 enrolled
NCT05580887 2022-10-14Intestinal Microbiota Impact for Prognosis and Treatment Outcomes in Early Luminal Breast Cancer and Pancreatic Cancer PatientsMoscow Clinical Scientific CenterUnknown35 enrolled
NCT00036790 2019-12-17Motexafin Gadolinium and Doxorubicin in Treating Patients With Advanced CancerUniversity of Wisconsin, MadisonPhase 1 Completed
NCT01375699 2019-08-26Doxorubicin With or Without Sildenafil, With Analysis of Cardiac MarkersVirginia Commonwealth UniversityPhase 1 Completed26 enrolled
NCT00003038 2011-08-03Combination Chemotherapy With Suramin Plus Doxorubicin in Treating Patients With Advanced Solid TumorsMayo ClinicPhase 1 Completed